LOADING
Comparing Mastercard Inc (MA) and AbbVie Inc (ABBV) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $508.6B | $468.2B |
| P/E Ratio | 32.0 | 74.6 |
| Forward P/E | 29.5 | 18.9 |
| PEG Ratio | 1.78 | 0.43 |
| EPS | $18.17 | $3.55 |
| Revenue Growth (YoY) | 14.1% | 10.2% |
| Profit Margin | 46.3% | 9.8% |
| Return on Equity | 241.2% | 62.3% |
| Dividend Yield | 0.59% | 2.61% |
| Beta | 0.73 | 0.28 |
| 52-Week High | $597.89 | $267.47 |
| 52-Week Low | $463.74 | $189.40 |
| Volume | -- | -- |
Mastercard Inc is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.